Advertisement

Picture EBD Group BioPharm America 2017 BPA Boston MA Partnering Opens 600x60px
Document › Details

Shimadzu Corporation. (9/24/13). "Press Release: Shimadzu U.S.A. Manufacturing Obtains ISO 13485 Quality Management Standard Certification for LC and LCMS Instruments. Concentrating Manufacture of Clinical-use Analytical Instruments in the U.S.".

Region Region Oregon (federal state)
  Country United States (USA)
Organisations Organisation Shimadzu U.S.A. Manufacturing Inc. (SUM)
  Organisation 2 Shimadzu Corporation
  Group Shimadzu (Group)
Products Product LC/MS system
  Product 2 diagnostic device, in vitro
Persons Person Matsunaga, Shinichi (Shimadzu 201309 President of Shimadzu USA Manufacturing Inc)
  Person 2 Nakamoto, Akira (Shimadzu 201504– Board Chairma before CEO)
     


Shimadzu U.S.A Manufacturing, Inc. (SUM) (Oregon, USA - President: Shinichi Matsunaga), the U.S. manufacturing subsidiary of Shimadzu Corporation (Kyoto, Japan - President: Akira Nakamoto), has obtained ISO 13485 certification for the manufacture of high-performance liquid chromatographs (LC) and high-performance liquid chromatograph mass spectrometers (LCMS). ISO 13485 is the globally recognized international quality management standard for medical equipment.

As a result of the increased use of analytical instruments in the clinical field, the U.S. FDA (Food and Drug Administration) announced draft guidance in June 2011, requiring a clearer distinction between research equipment and IVD (in vitro diagnostic devices). This demands a strict management system to ensure the reliability and accuracy of analytical instruments when used as medical equipment. Manufacturers must first comply with the ISO 13485 standard, and thereafter follow the laws and regulations in each country and region. In other words, obtaining ISO 13485 certification is now a prerequisite when using analytical instruments as medical equipment.

In April 2013, Shimadzu Corporation expanded the scope of its ISO 13485 certification, which covered blood coagulation and automatic clinical chemistry analyzers, to include LCMS and LC instruments. Obtaining ISO 13485 certification allows SUM to manufacture and supply analytical instruments for clinical testing to the U.S. market. Shimadzu will continue to register medical devices with the FDA, and support the growing demand for LC and LCMS in the clinical testing market.

"Mass spectrometry has a growing presence in clinical research and laboratory medicine," said Shinichi Matsunaga, President of Shimadzu U.S.A. Manufacturing. "Achieving ISO 13485 certification is a major milestone for Shimadzu and a great step towards developing mass spectrometry platforms as next generation medical devices."

Shimadzu U.S.A. Manufacturing (SUM) will continue to promote activities to obtain ISO 13485 certification for other analytical instruments planned to advance into the clinical testing market. In addition, SUM will build an efficient manufacturing system as a production base to supply medical equipment devices to customers throughout the world.

Simultaneous multicomponent analysis using Shimadzu's high-speed, high-sensitivity mass spectrometers is expected to demonstrate considerable value in the clinical field. Marking this occasion of ISO 13485 certification, Shimadzu will accelerate expansion of analytical and measuring instruments into the medical field and continue to fulfill our management principle of "Realizing Our Wishes for the Well-being of both Mankind and the Earth".

   
Record changed: 2016-03-19

Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

More documents for Shimadzu U.S.A. Manufacturing Inc. (SUM)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Partnering Opens 560x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Partnering Opens 560x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px